Media Partners

Pharmaceutical Pricing & Reimbursement in Central & Eastern Europe

Event Overview

This event will present a fresh and original perspective on communicating the cost-effectiveness of high-value drugs to key players and stakeholders in the former communist countries of Central and Eastern Europe (CEE EU members, The Balkans and the former Soviet states).

The conference will be unique because unlike other general, pan-European pricing & reimbursement meetings or broadly-focused CEE Pharma events, it will specifically focus on pricing &reimbursement of high value drugs in the CEE region. All participants will be exposed to the decision making processes of payers and other influential stakeholders in key markets and will achieve a clearer understanding of the different trends and reforms which will be taking place.

National governments in CEE are committed to increasing patient access to medicine and improving the quality of health care. However, although health budgets are generally increasing, payers are increasingly looking for better value for money, increasingly if this also means reimbursing the most expensive, but “cost-effective” drugs in the longer-term. Health technology assessment and determining “cost effectiveness” in a systematic way, has never been so important in CEE. HTA structures, agencies and concepts are developing quickly. With continued rapid economic growth and rising health spending, The CEE region still offers vast opportunities for pharmaceutical manufacturers and distributors to access and penetrate a range of therapeutic markets, both in the newer EU member states as well as those in the Balkans and the former Soviet Union.

Meet and hear opinions from senior figures representing distinct stakeholder groups: Ministries of health and their advisors, leading pharmaceutical companies, health-technology assessment experts, patient groups, respected health economists, senior hospital and health insurance representatives. Those attending will achieve a comprehensive understanding and complete picture of pricing & reimbursement models in key CEE countries. This will ensure the event’s attendees the ability to realise successful marketing strategies and to take market-access to the next level.

Why attend?

  • Hear experiences from ministries of health and industry leaders; overcome the challenges they are facing in times of transition and hear their most up to date solutions and future trends.
  • Learn how HTAs are being established and structured in CEE and understand the best ways to communicate value and achieve maximum patient and market access in the region.
  • Hear the perspectives of all stakeholder groups: Ministries of Health, HTA Agencies, Insurers, doctors, patient groups, health economists and the pharmaceutical industry.
  • Benchmark, network and co-operate with policy makers and key influencing figures. Get the best and most focused picture of reimbursements models today and get information about plans and reforms from a first source.

Who will benefit:

Pharmaceutical manufacturers:
Vice-Presidents, Directors, Managers involved in:
Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations,
Regulatory Affairs, Medical Affairs, Marketing, CEE Heads, Country Heads, Therapy Area Heads

Solution providers & consultants:
CEOs, Business Development, Senior Consultants, Regional Heads

Independent academics, health economists, senior doctors, & patient representatives.

Why Bratislava?

Sitting aside the Danube, and the capital of the Slovak Republic, Bratislava is emerging as an ideal venue for conferences. Its attractive, cosmopolitan and historical old town centre is an ideal location for relaxed business occasions.

Located close to Vienna (60km) and Budapest (250km) and easily accessible from the Czech Republic & Poland, Bratislava is proving to be a very convenient location for business in the centre of Europe.

How to fly to Bratislava?

Option 1: Bratislava International Airport
(Airlines: include SkyEurope, Ryanair, Lufthansa, CSA, LOT)

Option 2: Vienna International Airport
(and then just a 45 minute taxi ride!)

Confirmed Speakers/Panelists

Senior Ministry of Health
Representatives & Advisers:

Senior Consultant
CEE Society of Technology
Assessment in Healthcare
(Former Director of Drug Policy Department,
Polish National Health Fund)

Ministry Official
Pharmaceutical Department
Ministry of Health Czech Republic

Local Consultant for HTA
Project Coordination Unit
Ministry of Health, Serbia

Project Coordination Unit
Ministry of Health, Serbia

Head Expert
Ministry of Health Bulgaria

Coordinator,
Health Technology and Facilities Planning (TFP),
Department for Health System Governance
and Service Delivery (HDS)
World Health Organization, Geneva

Pharmaceutical Policy Expert
Gesundheit Österreich GmbH, Vienna

Industry Experts:

Chief Scientific Officer
creativ-ceutical

Executive Medical Director Eastern Europe
Amgen GmbH , Austria
Head Office for Central & Eastern Europe

European Manager Health Outcomes
Ethicon Endosurgery (Johnson & Johnson)

Health Outcomes Department Manager
GlaxoSmithKline, Poland

Pharmacoeconomics & Outcomes Research Manager
AstraZeneca Russia

Medical Marketing Director Czech Republic,
Leader, market access network, Central and Eastern Europe
AstraZeneca

Director,
Reimbursement and Health Economics,
Central & Eastern Europe Russia, Greece and Israel
Medtronic

Pricing and Reimbursement /
Outcomes Research Manager
Bristol-Myers Squibb, Poland

Former officer of the National Hungarian Health
Insurance Fund, Pricing and Reimbursement Manager Sanofi-Aventis Hungary

Respected Doctors:

University Hospital Zagreb
Member of Croatian Parliament,
Health and Social Welfare Committee

Market Access Advocates:

Professor of Healthcare Management Faculty
Moscow Medical Academy

Executive Director
Russian Society for
Pharmacoeconomics and Outcomes Research

Deputy Chief
Formulary Committee of
Russian Academy of Medical Sciences

Market Analysts:

Head, Department of Pharmacoeconomics
Medical University of Warsaw
President
Polish Society for Pharmacoeconomics

President
Sanigest Health Solutions

Contact Details

For Booking Information:
Tel: +421 232 662 621
Fax: +421 232 662 622
Email: pricing(at)nextlevelpharma.com

 
Home | Corporate Profile | Intelligent Events
Partnering Opportunities | Client Testimonials | Recruitment | Contact
Copyright 2008 @ All rights reserved
b2bsolutions.sk